Health News World

Breakthroughs in MASH Treatment: New FDA-Approved Medication and Lifestyle Strategies​

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a severe form of liver disease characterized by fat accumulation and inflammation in the […]